508 related articles for article (PubMed ID: 28878093)
1. Implications of microRNA dysregulation in the development of prostate cancer.
Massillo C; Dalton GN; Farré PL; De Luca P; De Siervi A
Reproduction; 2017 Oct; 154(4):R81-R97. PubMed ID: 28878093
[TBL] [Abstract][Full Text] [Related]
2. miRNAs as novel biomarkers in the management of prostate cancer.
Filella X; Foj L
Clin Chem Lab Med; 2017 May; 55(5):715-736. PubMed ID: 26751899
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA expression and function in prostate cancer: a review of current knowledge and opportunities for discovery.
Kumar B; Lupold SE
Asian J Androl; 2016; 18(4):559-67. PubMed ID: 27056344
[TBL] [Abstract][Full Text] [Related]
4. Recent scenario of microRNA as diagnostic and prognostic biomarkers of prostate cancer.
Shukla KK; Misra S; Pareek P; Mishra V; Singhal B; Sharma P
Urol Oncol; 2017 Mar; 35(3):92-101. PubMed ID: 27890424
[TBL] [Abstract][Full Text] [Related]
5. The Potential of MicroRNAs as Prostate Cancer Biomarkers.
Fabris L; Ceder Y; Chinnaiyan AM; Jenster GW; Sorensen KD; Tomlins S; Visakorpi T; Calin GA
Eur Urol; 2016 Aug; 70(2):312-22. PubMed ID: 26806656
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA in prostate cancer: Practical aspects.
Patil PA; Magi-Galluzzi C
Histol Histopathol; 2015 Dec; 30(12):1379-96. PubMed ID: 26186079
[TBL] [Abstract][Full Text] [Related]
7. Circulating microRNA signature for the diagnosis of very high-risk prostate cancer.
Alhasan AH; Scott AW; Wu JJ; Feng G; Meeks JJ; Thaxton CS; Mirkin CA
Proc Natl Acad Sci U S A; 2016 Sep; 113(38):10655-60. PubMed ID: 27601638
[TBL] [Abstract][Full Text] [Related]
8. Androgen receptor-regulated miRNA-193a-3p targets AJUBA to promote prostate cancer cell migration.
Jia L; Gui B; Zheng D; Decker KF; Tinay I; Tan M; Wang X; Kibel AS
Prostate; 2017 Jun; 77(9):1000-1011. PubMed ID: 28422308
[TBL] [Abstract][Full Text] [Related]
9. The role of microRNAs in prostate cancer migration, invasion, and metastasis.
Aghdam SG; Ebrazeh M; Hemmatzadeh M; Seyfizadeh N; Shabgah AG; Azizi G; Ebrahimi N; Babaie F; Mohammadi H
J Cell Physiol; 2019 Jul; 234(7):9927-9942. PubMed ID: 30536403
[TBL] [Abstract][Full Text] [Related]
10. The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy.
Humphries B; Yang C
Oncotarget; 2015 Mar; 6(9):6472-98. PubMed ID: 25762624
[TBL] [Abstract][Full Text] [Related]
11. Biomarker microRNAs for prostate cancer metastasis: screened with a network vulnerability analysis model.
Lin Y; Chen F; Shen L; Tang X; Du C; Sun Z; Ding H; Chen J; Shen B
J Transl Med; 2018 May; 16(1):134. PubMed ID: 29784056
[TBL] [Abstract][Full Text] [Related]
12. Missing link between microRNA and prostate cancer.
Gill BS; Alex JM; Navgeet ; Kumar S
Tumour Biol; 2016 May; 37(5):5683-704. PubMed ID: 26822307
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer early diagnosis: circulating microRNA pairs potentially beyond single microRNAs upon 1231 serum samples.
Liu HP; Lai HM; Guo Z
Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32607548
[TBL] [Abstract][Full Text] [Related]
14. The Landscape of microRNA Targeting in Prostate Cancer Defined by AGO-PAR-CLIP.
Hamilton MP; Rajapakshe KI; Bader DA; Cerne JZ; Smith EA; Coarfa C; Hartig SM; McGuire SE
Neoplasia; 2016 Jun; 18(6):356-70. PubMed ID: 27292025
[TBL] [Abstract][Full Text] [Related]
15. Epigenetics in prostate cancer: biologic and clinical relevance.
Jerónimo C; Bastian PJ; Bjartell A; Carbone GM; Catto JW; Clark SJ; Henrique R; Nelson WG; Shariat SF
Eur Urol; 2011 Oct; 60(4):753-66. PubMed ID: 21719191
[TBL] [Abstract][Full Text] [Related]
16. Roles of microRNAs during prostatic tumorigenesis and tumor progression.
Fang YX; Gao WQ
Oncogene; 2014 Jan; 33(2):135-47. PubMed ID: 23455326
[TBL] [Abstract][Full Text] [Related]
17. Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche.
Sánchez CA; Andahur EI; Valenzuela R; Castellón EA; Fullá JA; Ramos CG; Triviño JC
Oncotarget; 2016 Jan; 7(4):3993-4008. PubMed ID: 26675257
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA in prostate cancer: functional importance and potential as circulating biomarkers.
Jackson BL; Grabowska A; Ratan HL
BMC Cancer; 2014 Dec; 14():930. PubMed ID: 25496077
[TBL] [Abstract][Full Text] [Related]
19. Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer.
Fuse M; Kojima S; Enokida H; Chiyomaru T; Yoshino H; Nohata N; Kinoshita T; Sakamoto S; Naya Y; Nakagawa M; Ichikawa T; Seki N
J Hum Genet; 2012 Nov; 57(11):691-9. PubMed ID: 22854542
[TBL] [Abstract][Full Text] [Related]
20. Prognostic implications of tissue and serum levels of microRNA-128 in human prostate cancer.
Sun X; Yang Z; Zhang Y; He J; Wang F; Su P; Han J; Song Z; Fei Y
Int J Clin Exp Pathol; 2015; 8(7):8394-401. PubMed ID: 26339409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
